{"altmetric_id":421597,"counts":{"readers":{"mendeley":22,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["OncJournal"],"posts_count":1}},"selected_quotes":["Prognostic Model in Patients with Oxaliplatin or Irinotecan-Based First-Line Chemo for Metastatic Colorectal Cancer -"],"citation":{"abstract":"The present study was done to establish a prognostic model for patients and trials using an oxaliplatin-based or irinotecan-based first-line chemotherapy in metastatic colorectal cancer.","abstract_source":"pubmed","altmetric_jid":"4f6fa5ea3cf058f610005bda","doi":"10.1634\/theoncologist.2011-0039","first_seen_on":"2011-10-20T18:30:26+00:00","issns":["1549-490X"],"journal":"Oncologist","last_mentioned_on":1319133339,"links":["http:\/\/theoncologist.alphamedpress.org\/content\/16\/9\/1228.abstract"],"pdf_url":"http:\/\/theoncologist.alphamedpress.org\/content\/16\/9\/1228.full.pdf","pmid":"21859820","pubdate":"2011-01-01T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"Simplified Prognostic Model in Patients with Oxaliplatin-Based or Irinotecan-Based First-Line Chemotherapy for Metastatic Colorectal Cancer: A GERCOR Study","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/simplified-prognostic-model-patients-oxaliplatinbased-irinotecanbased-firstline-chemotherapy-metasta"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":5039474,"mean":5.9644629265799,"rank":2671795,"this_scored_higher_than_pct":33,"this_scored_higher_than":1695934,"rank_type":"exact","sample_size":5039474,"percentile":33},"similar_age_3m":{"total_number_of_other_articles":71478,"mean":4.570651510276,"rank":31242,"this_scored_higher_than_pct":38,"this_scored_higher_than":27838,"rank_type":"exact","sample_size":71478,"percentile":38},"this_journal":{"total_number_of_other_articles":1096,"mean":4.1723305936073,"rank":685,"this_scored_higher_than_pct":24,"this_scored_higher_than":269,"rank_type":"exact","sample_size":1096,"percentile":24},"similar_age_this_journal_3m":{"total_number_of_other_articles":14,"mean":6.2807692307692,"rank":9,"this_scored_higher_than_pct":14,"this_scored_higher_than":2,"rank_type":"exact","sample_size":14,"percentile":14}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Researcher":5,"Student  > Doctoral Student":3,"Student  > Ph. D. Student":2,"Other":4,"Student  > Master":5,"Lecturer":1,"Professor":1,"Unspecified":1},"by_discipline":{"Engineering":1,"Medicine and Dentistry":15,"Chemistry":1,"Agricultural and Biological Sciences":1,"Biochemistry, Genetics and Molecular Biology":3,"Unspecified":1}}},"geo":{"mendeley":{"US":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/#!\/OncJournal\/status\/127080550782603264","citation_ids":[421597],"posted_on":"2011-10-20T17:55:39+00:00","author":{"id_on_source":"OncJournal","tweeter_id":140057938},"tweet_id":"127080550782603264"}]}}